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Abstract
Background: Organophosphorus (OP) pesticide poisoning is the most common form of pesticide poisoning in
many Asian countries. Guidelines in western countries for management of poisoning indicate that gastric lavage
should be performed only if two criteria are met: within one hour of poison ingestion and substantial ingested
amount. But the evidence on which these guidelines are based is from medicine overdoses in developed countries
and may be irrelevant to OP poisoning in Asia. Chinese clinical experience suggests that OP remains in the
stomach for several hours or even days after ingestion. Thus, there may be reasons for doing single or multiple
gastric lavages for OP poisoning. There have been no randomised controlled trials (RCTs) to assess this practice
of multiple lavages. Since it is currently standard therapy in China, we cannot perform a RCT of no lavage vs. a
single lavage vs. multiple lavages. We will compare a single gastric lavage with three gastric lavages as the first stage
to assess the role of gastric lavage in OP poisoning.
Methods/Design: We have designed an RCT assessing the effectiveness of multiple gastric lavages in adult OP
self-poisoning patients admitted to three Chinese hospitals within 12 hrs of ingestion. Patients will be randomised
to standard treatment plus either a single gastric lavage on admission or three gastric lavages at four hour
intervals. The primary outcome is in-hospital mortality. Analysis will be on an intention-to-treat basis. On the basis
of the historical incidence of OP at the study sites, we expect to enroll 908 patients over three years. This
projected sample size provides sufficient power to evaluate the death rate; and a variety of other exposure and
outcome variables, including particular OPs and ingestion time. Changes of OP level will be analyzed in order to
provide some toxic kinetic data.
Discussion: the GLAOP study is a novel, prospective cohort study that will explore to the toxic kinetics of OP
and effects of gastric lavage on it. Given the poor information about the impact of gastric lavage on clinical
outcomes for OP patients, this study can provide important information to inform clinical practice.
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Background
Deliberate self-poisoning has reached epidemic propor-
tions in parts of the developing world where highly toxic
poisons and sparse medical facilities ensure a high fatality
rate. Pesticides are the major problem – the WHO esti-
mates that they cause more than 250,000 deaths world-
wide each year [1]. Most deaths are due to
organophosphorus (OP) insecticides [2].
Gastric lavage is a routine first aid procedure for self-poi-
soned patients in the People's Republic of China and
many Asia countries [3-6] but not in developed countries.
Guidelines used in the West suggest that gastric lavage
should only be used when two criteria are met: 1) the
patient presents within an hour of poison ingestion and
2) the amount of toxin is substantial [7]. If patients
present after one hour, the stomach contents are thought
to have likely passed into the small bowel so that gastric
lavage would not then be effective. In addition, if done
carelessly, gastric lavage may push gastric contents beyond
the pylorus, thereby enhancing absorption [7].
There is no evidence for the clinical effectiveness of gastric
lavage. During 1997, the American Academy of Clinical
Toxicology and European Association of Poisons Centres
and Clinical Toxicologists published reviews assessing the
value of a single gastric lavage on admission in acute self-
poisoning [8]. The position statement noted that serious
complications are associated with lavage and that there
were no studies of sufficient quality with which to assess
the clinical benefit of gastric lavage. The reports stressed
the importance of establishing high quality RCTs with
clinically relevant outcomes in order to determine the role
of gastric lavage in poisoning management.
However, we should note that the evidence on which the
European and American guidelines are based largely
involves overdoses of relatively safe pharmaceutical
agents in Western countries. It is not clear how relevant
such studies are to rural Asia where OP pesticides are often
ingested and the case fatality some 20–50 times higher
than the West. Furthermore, it is easier to aspirate liquid
pesticides than tablets because tablets can block the holes
at the end of the lavage tube [9].
To determine if there are any papers relevant to liquid OP
pesticide poisoning, we also carried out a Clinical Evi-
dence search and appraisal during 2005, plus a systematic
review of Medline, Embase, and Cochrane Collaboration
databases, to identify relevant RCTs looking at gastric lav-
age in OP poisonings. We were unable to find any studies
published in English or other European languages. We
subsequently searched the Chinese National Knowledge
Infrastructure. Although this identified over 500 papers
describing lavage in OP poisoned patients, none reported
RCTs. Overall, there is a lack of high-quality evidence on
the effectiveness of single or multiple gastric lavages in
acute human OP poisoning.
Current clinical practice in China is to give a single gastric
lavage to all patients with OP self-poisoning according to
the Chinese textbook [6]. Furthermore, the practice of giv-
ing multiple gastric lavages has become recently popular
from several non-randomised controlled trials performed
in China, despite the biases inherent in the study design.
For example, You and colleagues showed that repeated
lavages, every 2 hrs for 24–48 hrs, reduced mortality from
20.94% to 4.65% in a study of 86 patients [4]. Luo and
colleagues looked at lavages every 4–6 hrs for up to 24 hrs
and demonstrated a reduction in mortality from 47.5% to
14.6% [5]. Such studies, despite their methodological
weaknesses, suggest that the practice of giving multiple
gastric lavages must be assessed in a RCT.
The multiple lavage technique may work by removing
pesticide left in the stomach after the first lavage, pesticide
re-entering the stomach from the small bowel in the
supine patient, and/or pesticide secreted by the gastric
mucosa into the stomach (enterovascular circulation).
Chinese studies have found the concentration of OP in
stomach to be still high several hours or even days after
ingestion and gastric lavage [10,11]. This contrasts with
unpublished studies from Hanoi, Vietnam, which have
found little OP to be present after gastric lavage (Dawson,
personal communication).
Since gastric lavage is currently standard therapy in China,
we are not able to perform a RCT of no lavage vs. a single
lavage vs. multiple lavages. Instead, as a first step in a reas-
sessment of the role of gastric lavage in OP poisoned
patients, we have designed a trial comparing patients
receiving standard therapy plus either one lavage or three
lavages. If three lavages do not offer benefit over a single
lavage, it may then be appropriate to consider designing a
placebo controlled RCT of gastric lavage.
If three gastric lavages are shown to be beneficial, then
such lavages should be encouraged worldwide for OP pes-
ticide poisoning since the technique is cheap, widely
available, and reasonably safe once the airway is pro-
tected.
Methods/Design
The study is designed as an open RCT with two parallel
groups: a single gastric lavage on admission vs three gas-
tric lavages at four hour intervals from admission. Chinese
adult patients presenting to a secondary hospital with a
history of acute OP self-poisoning will be recruited to the
study.BMC Emergency Medicine 2006, 6:10 http://www.biomedcentral.com/1471-227X/6/10
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The trial has been drawn up and was designed to be com-
pliant with the Consolidated Standards of Reporting Tri-
als (CONSORT) statement.
Patients
The RCT will be performed in the emergency department
and/or the intensive care units (ICU) of the Harrison
International Peace Hospital in Hengshui He Bei Prov-
ince, the first Central Hospital in Baoding He Bei Prov-
ince, and the Wen Shang Hospital in Shan Dong Province.
All patients with a history of OP pesticide ingestion will
be approached concerning the study. Written informed
consent will be requested from conscious patients by a
study physician. Consent for unconscious adult patients
will be sought from accompanying relatives. Patients who
are unconscious on admission and present without rela-
tives will not be recruited to the trial.
Patients who do not give consent to recruitment will
receive usual care from the medical ward staff.
Inclusion and exclusion criteria
The study aims to recruit all patients admitted to the adult
medical wards of the study hospitals with a history of
acute oral OP pesticide self-poisoning 12 hours within
ingestion requiring atropine. Exclusion criteria will be: age
under 18 yrs; known pregnancy; co-ingestion of another
poison; and previous recruitment to the RCT.
Patient management
All patients will be seen on admission to the emergency
department and/or ICU wards, and resuscitated as neces-
sary by ward doctors together with study doctors. Stand-
ard treatment will be administered as described in figure
1[12].
We will use five markers for the routine assessment of
atropine requirements: miosis, sweating, poor air entry
into the lungs due to bronchorrhoea and bronchospasm,
bradycardia, and hypotension. If one of the markers is
present, we will give a 2 mg bolus of atropine. Markers of
sufficient atropine administration are a clear chest on aus-
cultation with no wheeze, heart rate >80 beats/min,
pupils no longer pinpoint, dry axillae and systolic blood
pressure >80 mmHg. If there is no improvement in five
minutes, the dose will be doubled and then doubled
again each time there is no response. The aim of atropine
therapy is to clear the chest and reach the end-points for
the chest, heart rate, and blood pressure. Once the patient
is atropinized, 10–20% of the total amount of atropine
required to load the patient will infused per hour, titrated
to the patient's condition.
Pralidoxime chloride will be given according to the proto-
col recommended by the World Health Organization, i.e.
a loading dose of 30 mg/kg over 20 min, followed by a
continuous infusion of at least 8–10 mg/kg per hour until
clinical recovery (for example 12–24 hours after atropine
is no longer required or the patient is extubated) or 7 days.
Lavage will be done as soon as a patient is stabilised and
resuscitated as above. Patients will receive gastric lavage
on admission, regardless of whether they have already
received it at another health centre.
Patients will remain under the care of the hospitals' con-
sultant physicians using management protocols agreed
between the consultants and study team. The ward medi-
cal teams will make decisions about intubation and trans-
fer of patients to intensive care or for cardiac pacing
independently of study doctors. All decisions are made on
the basis of clinical condition and do not reflect the poi-
son ingested or the times of lavages.
Patients will be seen regularly by doctors at least every
three hours and more often according to clinical need 24
hrs a day. Patients will also seen on a study ward round
twice each day (0830, 2030) at which time their condition
is recorded. Significant events (intubation, seizures,
death) will be recorded at the time of the event. The
patients' condition over the previous 12 hrs will be
reviewed at each ward round.
Patients will be first managed on the medical ward. Seri-
ously ill patients, as judged by the medical team, will be
transferred to ICU as a bed becomes available.
Criteria for intubation include respiratory rate of less than
10 breaths/minute, abdominal breathing, failure of non-
invasive methods to maintain a patent airway, or the frac-
tion of oxygen pressure to its concentration is lower than
300. Hypotensive patients, unresponsive to atropine and
fluid resuscitation, are treated with dopamine plus dob-
utamine as necessary.
Trial interventions and study procedures
Patients will be placed in left lateral position and a nose-
gastric tube placed through a nostril. Once in the stomach,
its position will be confirmed by aspirating gastric content
and auscultating over the stomach. The gastric content
will be sucked out first and then 300 ml of water at room
temperature pushed in. The water will then be aspirated
completely and another 300 ml administered. The above
procedures will be repeated until the aspirated water is
without smell and clear – this end point will be judged by
at least two doctors.BMC Emergency Medicine 2006, 6:10 http://www.biomedcentral.com/1471-227X/6/10
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Treatment protocol for OP poisoned patients Figure 1
Treatment protocol for OP poisoned patients.BMC Emergency Medicine 2006, 6:10 http://www.biomedcentral.com/1471-227X/6/10
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The above procedure will be repeated 4 hours and 8 hours
after the first gastric lavage in the group of patients receiv-
ing multiple lavages. 24 hours after admission, and after
gastric lavage and sample collection has been finished in
all groups, the gastric tube will be pulled out.
The procedure will be done by skilled medical staff. Vital
body signs, including ECG (electric cardiac graph) moni-
tor, blood pressure, heart rate, respiratory rate, and pulse
oxygen saturation will be monitored throughout the lav-
age. Patients will also be monitored for complications
such as aspiration. There should be no major problem
with compliance since the lavage will be given by the
study team.
A 10 ml blood sample will be taken using a sterile syringe
and needle from each patient on recruitment. Further 5 ml
blood samples will taken at one, four and twelve hours
post-treatment, and then at daily intervals until discharge
or death, from a subset of patients. Whether a needle or
indwelling cannula is used will be determined by the
wishes of the patient. The identity and blood concentra-
tion of the poison will be assayed retrospectively in a sub-
set of patients due to limited laboratory facilities.
A 10 ml sample of gastric aspirate will be taken at the
beginning of each gastric lavage so that the concentration
of pesticide present in the stomach can be calculated. The
volume of fluid aspirated before the first 300 ml of water
is given will be recorded.
Allocation of patients
Patients will be randomised to one of two study arms. The
random allocation sequence will be generated by compu-
ter and incorporated into a Microsoft Access programme
written for patient recruitment, randomisation and event
recording. Stratified block randomisation will be per-
formed according to patient status on admission (Glas-
gow coma score 14–15/15, Glasgow coma score <14/15).
The allocation sequence will be generated independently
by the study statistician and programmer, who will have
no role in patient recruitment, treatment or assessment.
Variable block sizes of 3, 6 and 9 will be used to allocate
patients in equal numbers to each treatment group i.e.
ratio 1:1.
Participants will be recruited and randomised by a study
doctor at the bedside using a dedicated handheld compu-
ter at each study hospital. Randomisation will occur after
the patient's baseline data have been entered and receipt
of consent noted, and cannot be manipulated by study
doctors. The recruiting doctor will be unable to predict
allocation before randomisation.
All practical steps have been taken to avoid bias: (i) the
randomisation program has been designed to be rapid
and simple to operate, and yet remain independent of the
investigators; (ii) the next treatment allocation cannot be
predicted in advance; (iii) the primary outcome, vital sta-
tus at discharge, is unambiguous, and the secondary out-
comes are objective; (iv) all outcomes are recorded by the
study team, not other hospital physicians;
(v) patient follow-up should be near 100% complete; and
(vi) the analysis will be performed on an intention-to-
treat basis.
Outcomes
The primary outcome is all-cause mortality during hospi-
tal admission.
Secondary outcomes include proportion of patients
requiring intubation for respiratory failure; period of ven-
tilation; proportion of patients developing the intermedi-
ate syndrome; and 50% recovery time for red cell
acetylcholinesterase enzyme activity.
Sample size
In all three patient enrolled hospitals, at least 15% of poi-
soned patients die before discharge[6]. An absolute reduc-
tion of 6% will be clinically important. In order to be able
to detect whether multiple gastric lavage reduces the death
rate from 15% to 9%, with a significance level (alpha) of
5% and a power of 80%, a minimum of 454 patients must
be recruited to each arm of the trial (i.e. 908 patients in
total).
There should be no loss to follow up for the primary out-
come. Patients will either be discharged alive from the
wards or their bodies transferred to the morgue for judi-
cial autopsy. Secondary clinical outcomes will be assessed
in hospital before patient discharge; red cell AChE will be
measured in a subset of patients by a laboratory blind to
allocation.
Study hypotheses and planned analyses
The main hypothesis is that multiples gastric lavages will
reduce the case fatality rate from 15% to 9%, hence the
primary comparison will be of multiple lavages with a sin-
gle lavage.
It is possible that multiple lavages will be more effective
the earlier they are started. Therefore we will assess the
trends in clinical effectiveness according to time post-
ingestion to start of therapy. In order to determine
whether treatment should be started irrespective of sever-
ity, we will also assess trends in case fatality rates across a
gradient of severity.BMC Emergency Medicine 2006, 6:10 http://www.biomedcentral.com/1471-227X/6/10
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Subgroup analyses are planned to look at the consistency
of treatment effect across particular OPs that are common
in China, eg. dichlorvos, phorate, dimethoate. Analyses
will also be done to check whether ingestion of a meal
within one hour of the ingestion affects outcome.
Admission blood and stomach content samples will be
retrospectively analysed to determine the identity of the
poison ingested. The primary analyses will then be
repeated with correction for the identity of the poison.
The time-dependent variations of OP level will be ana-
lysed in order to provide OP toxic kinetic data.
Statistical analysis
The main analysis will be carried out on an intention-to-
treat basis, using the chi squared test for the primary out-
come (or Fisher's exact test if appropriate) and for other
dichotomous outcomes. Relative risk (plus risk reduc-
tion), absolute risk reduction and number needed to treat
(plus 95% confidence intervals) will also be calculated.
For outcomes where time-to-event is recorded, the log
rank test will be used to compare treatment groups. In
addition, a Kaplan-Meier curve will be produced to illus-
trate the comparison of mortality between groups.
An analysis of trends in treatment effect for factors
'reported time from ingestion to treatment' and 'patient
status on admission' will also be performed using statisti-
cal modelling techniques.
Data Monitoring and Ethics Committee (DMEC)
An independent DMEC has been established for the trial.
For the duration of recruitment, interim analyses will be
supplied by the trial statistician, in strict confidence, to the
DMEC, together with any other analyses the DMEC may
request. The data will be supplied to the Chair of the
DMEC as often as he requests. Meetings will be arranged
periodically, as considered appropriate by the Chair. In
the light of interim data, and other evidence from relevant
studies, the DMEC will inform the principal investigator
(Dr Li Yi), if in their view (i) there is proof beyond reason-
able doubt that the data indicate that any part of the pro-
tocol under investigation is clearly indicated or contra-
indicated, either for all participants or for a particular sub-
group of trial participants, or (ii) it is evident that no clear
outcome will be obtained.
The decision to inform the principal investigator in either
of these circumstances will, in part, be based on statistical
considerations. Appropriate criteria for proof beyond rea-
sonable doubt cannot be specified precisely. A difference
of at least three standard deviations in the interim analysis
of the major endpoint may be needed to justify halting, or
modifying, such a study prematurely. If this criterion were
to be adopted, it would have the practical advantage that
the exact number of interim analyses would be of little
importance, and so no fixed schedule is proposed [13].
Unless modification or cessation of the protocol is recom-
mended by the DMEC, the principal investigator, co-
investigators, collaborators and administrative staff will
remain ignorant of the results of the interim analyses. Col-
laborators and all others associated with the study may
write to the Chair of the DMEC to draw attention to any
concern they may have about the possibility of harm aris-
ing from the treatment under study, or any other matter
that may be relevant. The principle investigator will fol-
low the advice of the Chairman concerning decisions to
continue or stop the trial.
The members of the DMEC for this study are:
Dr Bin Du, Dept of Medicine Intensive Care Unit, Peking
Union Medical College Hospital (Chairman)
Professor Andrew Dawson, Dept of Medicine, University
of Peradenya, Sri Lanka
Professor Abul Faiz Dept of Medicine, Dhaka Medical
College, Bangladesh
Professor Lau Fei Lung, Hong Kong Poison Control
Center, Hong Kong, China
Dr. ShaoMei Han, Dept of Statistics, Peking Union Medi-
cal College Hospital (Statistician)
Professor Ji Jiang, Dept Pharmaceulogy, Peking Union
Medical College Hospital
Discussion
The GLAOP study is a multi-site, prospective cohort study
that seeks to evaluate the impact of gastric lavage, particu-
lar OP and ingestion time etc. on a variety of important
outcomes. Whereas previous studies of gastric lavage have
measured the outcomes in drug overdosers[8], the
GLAOP study is distinguished by its large sample size of
OP patients and its comprehensive measurement of poi-
son levels. Building on these strengths allows the GLAOP
study to evaluate the impact, and associated mechanisms
of gastric lavage action on longer-term patient outcomes,
and to generate hypotheses for future research. Ulti-
mately, the GLAOP study seeks to inform clinicians about
the gastric lavage therapy in pesticide poisoning, so as to
facilitate change in clinical practice and improve out-
comes for pesticide poisoning patients. The GLAOP study
has potential limitations. First, besides times of gastric lav-
age, there are many known factors influencing the result.
These include ingestion time, particular OP, amount of
ingestion, the underlying disease and so on. Furthermore
some important factors may be unknown or unmeasured,BMC Emergency Medicine 2006, 6:10 http://www.biomedcentral.com/1471-227X/6/10
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resulting in residual confounding and bias. If these differ-
ences are associated with the outcomes of interest, the
study results may be difficult to analyze. Fortunately, soft-
ware for the randomization has been used in the triage of
the trial. Second, because of the ethic concern, group with-
out lavage at all can not be set up in China to investigate
its role in OP patients directly. No matter what result was
put out, single lavage better or multiple lavages better, it is
difficult to put forward the trial further because of the dif-
ferent ethic concerns in the world. For example, if multi-
ple lavage shows no better than single lavage, it is a long
journey to set up a RCT to explore the difference between
single lavage and no lavage in China. Third, although
drawn from 3 different medical centers and a treatment
protocol has been used, all these hospitals are in China;
thus, the GLAOP study results may not generalize to OP
patients in other settings.
These limitations suggest several directions for future
studies. First, the design of future randomized trials of gas-
tric lavage. Narrow the inclusion criteria of OP patients,
then the respective factors can be studied better. Second,
in order to put forward relative studies thereafter, commu-
nications with experts in the world are necessary. Winning
the understanding of the trial and its importance, it will be
better to accomplish the trials. Finally, additional observa-
tional studies especially taken outside of China should be
conducted to assess the generalizability of findings from
the GLAOP study.
In summary, the GLAOP study is a prospective cohort
study that seeks to provide new knowledge about the asso-
ciation of gastric lavage, particular OP and other aspects of
OP with the patient outcomes. Strengths of the study
include comprehensive measurement of samples and out-
comes, and a relatively large projected sample size. Results
from the GLAOP study should help to explore to the toxic
kinetics of OP and effects of gastric lavage on it, help to
improve the care and outcomes of OP patients.
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